QUINNE SEMBER
HOUSTON, TX
Browse related groups: TX GENZYME CORPORATION All categories
This page merges CMS profile IDs: 11306735, 11310510 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$3,032.21
- Category: General Payments
- Program years: PY2021–2024
- Record count: 93
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,016.95 across 30 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $916.96 | 29 |
| Education | $99.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $185.77 | 3 |
| AVEO Pharmaceuticals, Inc. | $142.03 | 3 |
| SOBI, INC | $114.10 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $102.61 | 4 |
| PharmaEssentia USA Corporation | $91.82 | 3 |
| Alexion Pharmaceuticals, Inc. | $64.74 | 2 |
| EISAI INC. | $45.68 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.96 | 1 |
| Rigel Pharmaceuticals, Inc. | $32.86 | 1 |
| Regeneron Healthcare Solutions, Inc. | $29.98 | 1 |
| Tempus AI, Inc | $29.58 | 1 |
| ADC Therapeutics America, Inc. | $28.35 | 1 |
| Exelixis Inc. | $28.16 | 1 |
| BeiGene USA, Inc. | $28.09 | 1 |
| Acerta Pharma LLC | $21.79 | 1 |
| Incyte Corporation | $20.45 | 1 |
| Janssen Biotech, Inc. | $17.98 | 1 |
By program year
Records — PY2024 (30)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11306735, 11310510
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.